You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

October 7, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

5 ways formulary managers can brace for Ebola

Find out what measures you can take in helping to cope with the arrival of an Ebola patient in your medical facility. » 5 aspects to consider in the face of this potentially serious healthcare concern

Distribution changes for top cancer drugs cause hospitals to protest

Genentech has announced a major change in the distribution process for their 3 top cancer drugs: Avastin (bevacizumab), Herceptin (trastuzumab), and Rituxan (rituximab). Now, distribution of the drugs to hospitals and clinics will be restricted to authorized specialty distributors. » Read the reaction of hospitals and pharmacy execs

Continuing Education

MTM essentials for anticoagulant management in cardiovascular disease

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacological properties, safety and efficacy, and risk/benefit profile for the various anticoagulant medications used in cardiovascular diseases.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT10-VXP89.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

[VIDEO] Patient access to orphan drugs faces new set of challenges

The growing numbers of orphan drugs in the market and the high cost of certain orphan treatments have led to a reconsideration of payer reimbursement policies.
» Check out the breakdown of orphan drugs by therapeutic category

 

Related Articles

WHO okays experimental drug use in Ebola outbreak

Plan nixes markup on cancer drugs

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group